Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Fleming Outeiro

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Molecular Neurobiology|January 7, 2021
Alpha-Synuclein Antibody Characterization: Why Semantics MattersTiago Fleming Outeiro
Nature|September 27, 2006
A bridge from Portugal to the StatesTiago Fleming Outeiro
EMBO Reports|February 21, 2020
The courage to change scienceTiago Fleming Outeiro
Journal of Neurochemistry|December 10, 2020
Alpha-synuclein oligomerization and aggregation: A model will always be a model: This is a response to "Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get". Read the reply on "Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model". The articles are accompanied by a Preface "How good are cellular models?"Tiago Fleming Outeiro
Acta Neuropathologica|February 24, 2021
Emerging concepts in synucleinopathiesTiago Fleming Outeiro
FEMS Yeast Research|June 29, 2010
Simple is good: yeast models of neurodegenerationSandra Tenreiro, Tiago Fleming Outeiro
Molecular Neurobiology|February 8, 2013
Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopySusana Gonçalves, Tiago Fleming Outeiro
Current Pharmaceutical Design|September 16, 2009
Current and future therapeutic strategies for Parkinson's diseaseTiago Fleming Outeiro, Joaquim Ferreira
Perspectives in Medicinal Chemistry|September 30, 2009
Drug Targeting of alpha-Synuclein Oligomerization in SynucleinopathiesTiago Fleming Outeiro, Aleksey Kazantsev
Brain : a Journal of Neurology|August 1, 2023
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathiesAvika Chopra, Tiago Fleming Outeiro
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Molecular Neurobiology|January 7, 2021
Alpha-Synuclein Antibody Characterization: Why Semantics MattersTiago Fleming Outeiro
Nature|September 27, 2006
A bridge from Portugal to the StatesTiago Fleming Outeiro
EMBO Reports|February 21, 2020
The courage to change scienceTiago Fleming Outeiro
Journal of Neurochemistry|December 10, 2020
Alpha-synuclein oligomerization and aggregation: A model will always be a model: This is a response to "Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get". Read the reply on "Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model". The articles are accompanied by a Preface "How good are cellular models?"Tiago Fleming Outeiro
Acta Neuropathologica|February 24, 2021
Emerging concepts in synucleinopathiesTiago Fleming Outeiro
FEMS Yeast Research|June 29, 2010
Simple is good: yeast models of neurodegenerationSandra Tenreiro, Tiago Fleming Outeiro
Molecular Neurobiology|February 8, 2013
Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopySusana Gonçalves, Tiago Fleming Outeiro
Current Pharmaceutical Design|September 16, 2009
Current and future therapeutic strategies for Parkinson's diseaseTiago Fleming Outeiro, Joaquim Ferreira
Perspectives in Medicinal Chemistry|September 30, 2009
Drug Targeting of alpha-Synuclein Oligomerization in SynucleinopathiesTiago Fleming Outeiro, Aleksey Kazantsev
Brain : a Journal of Neurology|August 1, 2023
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathiesAvika Chopra, Tiago Fleming Outeiro
Pageof 15